Travere Therapeutics Inc (NASDAQ:TVTX)
| 20.28 BATS BZX Real-Time Price As of 3:45pm ET |  -0.68 / -3.24%Today’s Change | 17.82 Today|||52-Week Range 30.35 | -3.57% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $1.6B |
Company Description
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Contact Information
Travere Therapeutics, Inc. 3611 Valley Centre Drive San Diego California 92130 |
Employees
Shareholders
| Other institutional | 76.26% |
| Mutual fund holders | 39.39% |
| Individual stakeholders | 1.29% |
Top Executives
| Eric M. Dube | President, Chief Executive Officer & Director |
| Chris Cline | Chief Financial Officer |
| Bill Rote | Senior VP, Head-Research & Development |
| Jula Inrig | Chief Medical Officer |
| Elizabeth E. Reed | Secretary, Senior Vice President & General Counsel |
